(Total Views: 111)
Posted On: 03/19/2021 10:10:49 AM
Post# of 36254

$CLVS News Article - Clovis Oncology's Rubraca (rucaparib) Significantly Improves Progression-Free Survival versus Chemotherapy in Patients with Later-line Ovarian Cancer Associated with a BRCA Mutation https://marketwirenews.com/news-releases/clov...51787.html


My Twitter: WhyteStocks